Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. Oncology (Williston Park). 2003 May; 17(5 Suppl 5):52-5.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents, Phytogenic
Camptothecin
Glucuronosyltransferase
Humans
Neoplasms
Polymorphism, Genetic
Syndrome
authors with profiles
Mark Ratain